Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
3.130
-0.060 (-1.88%)
At close: Aug 21, 2026, 4:00 PM EDT
3.180
+0.050 (1.60%)
After-hours: Aug 21, 2026, 7:30 PM EDT
Cabaletta Bio Market Cap
Cabaletta Bio has a market cap or net worth of $530.68 million as of August 21, 2026. Its market cap has increased by 267.21% in one year.
Market Cap
530.68M
Enterprise Value
331.29M
1-Year Change
267.21%
Ranking
Category
Stock Price
$3.13
ChartMarket Cap Chart
Since October 25, 2019, Cabaletta Bio's market cap has increased from $235.53M to $530.68M, an increase of 125.31%. That is a compound annual growth rate of 12.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 530.68M | 151.72% |
| Dec 31, 2025 | 210.82M | 90.01% |
| Dec 31, 2024 | 110.95M | -88.59% |
| Dec 29, 2023 | 972.68M | 260.85% |
| Dec 30, 2022 | 269.55M | 151.03% |
| Dec 31, 2021 | 107.38M | -64.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zura Bio | 560.60M |
| Entera Bio | 559.25M |
| ARS Pharmaceuticals | 547.46M |
| Ovid Therapeutics | 546.83M |
| Artiva Biotherapeutics | 534.37M |
| Rezolute | 531.74M |
| Kyverna Therapeutics | 520.72M |
| MapLight Therapeutics | 519.90M |